BRUSSELS, Belgium - European Union generosity in supporting biotech research is being qualified by persistent concessions to the diversity of ethical views across the EU's 27 member states. (BioWorld International)

View All Articles by Peter O'Donnell

Peter O'Donnell

ARTICLES

Pharma 'Blocked Innovation,' EU Authorities Charge

Biofirms See Rare Diseases Initiative as Lever on Pricing

Europe's Biofirms Alarmed at Animal Testing Controls

Europe Stumbles over New Pharma Rules

Easier Rules Advanced for Product Variations

Firms Say Advanced Therapies Still Lack Clear EU Definition

Biopharma Group Applauds Results of High-Level Forum

European Health Lobbies Look for 2009 Policy Opportunities

Poland and EU Head for New GM Law Clash

European Research Funding Caught in Ethical Controls

Today's news in brief

Today's news in brief

City hits the town with $1B-plus deal with Biogen

Salvia raises $60M for neuromodulation migraine system

News in brief